OFEV® (nintedanib) time to face IPF head on Who to treat? Eligible patients across CTD-ILDs Document ID: PC-ZA-102069 04/05/2023 Author: Boehringer Ingelheim Patient identification RELATED CONTENT PC-ZA-102069 Production date: May 2023
